Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells

• Published in: Scandinavian journal of gastroenterology 2011-07, Vol.46 (7-8), p.903-912
• Main Authors: Walczak, Katarzyna, D browski, Wojciech, Langner, Ewa, Zgrajka, Wojciech, Pi at, Jacek, Kocki, Tomasz, Rzeski, Wojciech, Turski, Waldemar A.
• Format: Article
• Language: English
• Subjects: Adenocarcinoma, Mucinous - metabolism; Adenoma - metabolism; Biological and medical sciences; Caco-2 Cells; Cecum - enzymology; Cecum - metabolism; Cell Proliferation; colon cancer; Colon epithelium; Colon, Ascending - enzymology; Colon, Ascending - metabolism; Colonic Neoplasms - metabolism; Colonic Polyps - metabolism; Female; Gastroenterology. Liver. Pancreas. Abdomen; HT29 Cells; Humans; kynurenic acid; Kynurenic Acid - analysis; Kynurenic Acid - metabolism; kynurenine aminotransferases; Male; Medical sciences; Middle Aged; Mucus - chemistry; Mucus - metabolism; proliferation; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Transaminases - metabolism; Tumors
• ISSN: 0036-5521; 1502-7708
• DOI: 10.3109/00365521.2011.579159

Abstract Background. Kynurenic acid (KYNA), a tryptophan metabolite, was found in human saliva, gastric juice, bile, pancreatic juice and mucus of rat small intestine. Methods. KYNA content in mucus aspirated from human caecum or colon ascendens and KYNA production in colon epithelial and cancer cells were determined using HPLC. Moreover, biological properties of KYNA and kynurenine aminotransferases (KATs) expression in colon epithelial and colon cancer cells were studied. Results. Considerably higher KYNA concentration was detected in samples from patients diagnosed with colon carcinoma (269.40 ± 107.00 pmol/ml, N = 4), Adenoma tubulovillosum (200.50 ± 36.72, N = 10) or Adenoma tubulare (243.50 ± 38.09, N = 9) than in control group (82.22 ± 7.61 pmol/ml, N = 30). Moreover, colon epithelium CCD 841 CoTr cells actively synthesized KYNA in a concentration- and time-dependent manner. This process was decreased by aminooxyacetic acid and L-glutamate in opposite to 4-aminopyridine treatment. Interestingly, KYNA production in colon cancer cells (HT-29 1.39 ± 0.27, LS-180 1.18 ± 0.15 and Caco-2 4.21 ± 0.30 pmol/1 × 105 cells/2 h) was considerably higher in comparison to normal colon epithelial cells (0.70 ± 0.07 pmol/1 × 105 cells/2 h). However, KATs I and II were expressed at similar level in both colon epithelium and cancer cells. Furthermore, KYNA exerted an antiproliferative effect at higher micro- and milimolar concentrations against colon cancer cells with the IC50 of 0.9, 0.2 and 1.2 mM for HT-29, LS-180 and Caco-2 cells, respectively. Conclusion. Summarizing, this is the first report presenting KYNA synthesis and KAT expression in colon derived normal and cancer cells.